Dr. Vavvas joins OliX Pharma’s Scientific Advisory Board

OliX Pharmaceuticals, a leading developer of RNAi therapeutics has announced that Demetrios G. Vavvas, M.D., Ph.D., one ...

April 22, 2019 | Monday | News
GC Pharma joins the Bleeding Disorder's Community to celebrate World Hemophilia Day

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company joins World Hemophilia D...

April 16, 2019 | Tuesday | News
Celltrion, iProgen Biotech to develop a series of novel ADCs

South Korea-based Celltrion and the Canada-based iProgen Biotech has announced to agree  to partner for the de...

April 9, 2019 | Tuesday | News
West Pharma expands APAC biz with new Korean office

West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, has expanded i...

April 5, 2019 | Friday | News
Standigm raises $11.5M in Series B Round

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...

April 2, 2019 | Tuesday | News
GCAM opens new plasma collection centre

GCAM, Inc., headquartered in Fullerton, CA, was established in 2009 and a member of South Korea's GC grou...

March 26, 2019 | Tuesday | News
LegoChem Biosciences, Takeda collaborate for immuno-oncology research

LegoChem Biosciences has announced that it has entered a research collaboration and license agreement with Takeda Pharma...

March 25, 2019 | Monday | News
PDC*line Pharma enters into a licensing agreement with LG Chem

PDC*line Pharma, a biotech company developing a new class of potent and scalable antigen presenting cell, based on a pro...

March 22, 2019 | Friday | News
Samsung BioLogics wins CMO leadership awards in six categories

Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based i...

March 22, 2019 | Friday | News
ACell enters distribution agreement for wound management

ACell, Inc. a leading regenerative medicine company, has recently announced that it has entered into an exclusive distri...

March 20, 2019 | Wednesday | News
Théa, OliX to develop RNAi therapies for AMD treatment

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and col...

March 18, 2019 | Monday | News
ResMed completes acquisition of HB Healthcare

ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has announced ...

March 14, 2019 | Thursday | News
Medical Korea 2019 to explore global healthcare era

The global healthcare and medical tourism conference "Medical Korea 2019" will be held for three days from March 14 at G...

March 6, 2019 | Wednesday | News
Can-Fite expands its Namodenoson Distribution Deal with CKD

Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...

February 27, 2019 | Wednesday | News
ABL Bio, WuXi Bio expand strategic collaboration for $220M

WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...

February 26, 2019 | Tuesday | News
Xynomic Pharma doses first South Korean patient in Phase 3 RCC trial

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly ...

February 25, 2019 | Monday | News
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study

Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...

February 22, 2019 | Friday | News
Korean govt to inject $2.6B to develop biotech in 2019

According to reports from the Korean Herald,  the government of Korea will spend 2.93 trillion won (US$2.61 billion...

February 20, 2019 | Wednesday | News